Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
September 07 2022 - 8:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that Jerry Durso, President and Chief Executive Officer
of Intercept, and Andrew Saik, Chief Financial Officer of
Intercept, will participate in fireside chats and investor meetings
at the following upcoming investor conferences:
- The H.C. Wainwright 24th Annual Global Investment Conference,
for which the chat will be taking place on September 13th, 2022,
from 5:00-5:30pm ET.
- The Baird Global Healthcare Conference, for which the chat will
be taking place on September 14th, 2022, from 9:05-9:35am ET.
The fireside chats can be accessed on the investor page of
Intercept’s website at http://ir.interceptpharma.com.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). For more information, please
visit www.interceptpharma.com or connect with the company
on Twitter and LinkedIn.
ContactFor more information about Intercept,
please contact:
Investor inquiries: investors@interceptpharma.comMedia
inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2023 to Apr 2024